{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:21:15Z","timestamp":1792686075717,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL150568"],"award-info":[{"award-number":["U01HL150568"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA048206"],"award-info":[{"award-number":["R01DA048206"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A subset of individuals without a history of prolonged or problematic opioid use demonstrate attenuated subjective responses to orally administered opioids despite physiological and analgesic responses. This phenotype may confer elevated risk for greater analgesic requests and physiologic dependence, but it is unclear if this is driven by differences in route of administration. This study evaluated responses to cumulative dosing of parenteral hydromorphone, versus placebo, in persons without a history of significant opioid use to further identify and characterize this subgroup. Individuals without opioid use disorder (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200982) were exposed to a cumulative hydromorphone dosing procedure, during which they completed measures of subjective effects and were assessed for physiological opioid responses. Linear mixed effects regressions were used to examine changes in subjective and physiological measures as a function of responder phenotype, drug condition, and time. Approximately 31.7% of the sample were classified as Opioid Non-Responders. These individuals had attenuated changes in subjective responses to hydromorphone relative to other participants, despite equivalent physiological responses. Race and sex did not predict Opioid Responder status. These findings confirm the presence of a \u201cOpioid Non-Responder\u201d phenotype for the first time in the context of a cumulative, parenteral dosing paradigm. Further research is warranted to elucidate the clinical implications and potential risk or protective factors underlying this phenotype.\n                  <\/jats:p>","DOI":"10.1038\/s41386-025-02271-4","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T04:50:24Z","timestamp":1763441424000},"page":"455-463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reliable variability in subjective responses to parenteral hydromorphone administration: empirical confirmation of an opioid non-responder phenotype"],"prefix":"10.1038","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8156-6772","authenticated-orcid":false,"given":"Jennifer D.","family":"Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor Blair","family":"Towers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siny","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci","family":"Speed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6819-1112","authenticated-orcid":false,"given":"Sheera F.","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2542-9798","authenticated-orcid":false,"given":"Michelle","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-6150","authenticated-orcid":false,"given":"Wendy","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8482-5461","authenticated-orcid":false,"given":"Eric C.","family":"Strain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Finan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"2271_CR1","doi-asserted-by":"publisher","first-page":"e2417651","DOI":"10.1001\/jamanetworkopen.2024.17651","volume":"7","author":"D Alessio-Bilowus","year":"2024","unstructured":"Alessio-Bilowus D, Chua K-P, Peahl A, Brummett CM, Gunaseelan V, Bicket MC, et al. Epidemiology of Opioid Prescribing After Discharge From Surgical Procedures Among Adults. JAMA Netw Open. 2024;7:e2417651.","journal-title":"JAMA Netw Open"},{"key":"2271_CR2","doi-asserted-by":"publisher","first-page":"e234731","DOI":"10.1001\/jamahealthforum.2023.4731","volume":"5","author":"LD Allen","year":"2024","unstructured":"Allen LD, Pollini RA, Vaglienti R, Powell D. Opioid Prescribing Patterns After Imposition of Setting-Specific Limits on Prescription Duration. JAMA Health Forum. 2024;5:e234731.","journal-title":"JAMA Health Forum"},{"key":"2271_CR3","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/pme.12668","volume":"16","author":"JGJ Pierik","year":"2015","unstructured":"Pierik JGJ, IJzerman MJ, Gaakeer MI, Berben SA, Van Eenennaam FL, Van Vugt AB, et al. Pain Management in the Emergency Chain: The Use and Effectiveness of Pain Management in Patients with Acute Musculoskeletal Pain. Pain Med. 2015;16:970\u201384.","journal-title":"Pain Med"},{"key":"2271_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1037\/pha0000039","volume":"23","author":"MJ Worley","year":"2015","unstructured":"Worley MJ, Heinzerling KG, Shoptaw S, Ling W. Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain. Experimental Clin Psychopharmacol. 2015;23:428\u201335.","journal-title":"Experimental Clin Psychopharmacol"},{"key":"2271_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/SLA.0000000000001993","volume":"265","author":"MV Hill","year":"2017","unstructured":"Hill MV, McMahon ML, Stucke RS, Barth RJ. Wide Variation and Excessive Dosage of Opioid Prescriptions for Common General Surgical Procedures. Annals Surg. 2017;265:709\u201314.","journal-title":"Annals Surg"},{"key":"2271_CR6","doi-asserted-by":"crossref","unstructured":"Dunn KE, Barrett FS, Fingerhood M, Bigelow GE. Opioid Overdose History, Risk Behaviors, and Knowledge in Patients Taking Prescribed Opioids for Chronic Pain. Pain Med. 2017;18:1505\u201315.","DOI":"10.1093\/pm\/pnw228"},{"key":"2271_CR7","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1016\/j.pain.2013.07.046","volume":"154","author":"J Hjsted","year":"2013","unstructured":"Hjsted J, Ekholm O, Kurita GP, Juel K, Sjgren P. Addictive behaviors related to opioid use for chronic pain: A population-based study. Pain. 2013;154:2677\u201383.","journal-title":"Pain"},{"key":"2271_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.drugalcdep.2013.01.001","volume":"132","author":"DG Antoine","year":"2013","unstructured":"Antoine DG, Strain EC, Tompkins DA, Bigelow GE. Opioid abusers\u2019 ability to differentiate an opioid from placebo in laboratory challenge testing. Drug Alcohol Depend. 2013;132:369\u201372.","journal-title":"Drug Alcohol Depend"},{"key":"2271_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2023.100188","volume":"8","author":"CJ Durgin","year":"2023","unstructured":"Durgin CJ, Huhn AS, Bergeria CL, Finan PH, Campbell CM, Antoine DG, et al. Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes. Drug Alcohol Depend Rep. 2023;8:100188.","journal-title":"Drug Alcohol Depend Rep"},{"key":"2271_CR10","doi-asserted-by":"crossref","unstructured":"McKendrick G, Durgin C, Huhn A, Bergeria C, Finan P, Antoine D, et al. Inter-Individual Divergence in Thresholds for Detecting Opioid Effects: Within-subject Human Laboratory Evidence of a Testable Behavioral Phenotype. Drug Alcohol Depend.2025;2025.","DOI":"10.1016\/j.drugalcdep.2025.112644"},{"key":"2271_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","volume":"84","author":"HS Smith","year":"2009","unstructured":"Smith HS. Opioid Metabolism. Mayo Clin Proc. 2009;84:613\u201324.","journal-title":"Mayo Clin Proc"},{"key":"2271_CR12","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1038\/s41436-018-0431-8","volume":"21","author":"DM Smith","year":"2019","unstructured":"Smith DM, Weitzel KW, Elsey AR, Langaee T, Gong Y, Wake DT, et al. CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial. Genetics Med. 2019;21:1842\u201350.","journal-title":"Genetics Med"},{"key":"2271_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/PGPM.S239222","volume":"13","author":"GS Lopes","year":"2020","unstructured":"Lopes GS, Bielinski SJ, Moyer AM, Black Iii JL, Jacobson DJ, Jiang R, et al. Sex Differences in Associations Between CYP2D6 Phenotypes and Response to Opioid Analgesics. PGPM. 2020;13:71\u20139.","journal-title":"PGPM"},{"key":"2271_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/PGPM.S136341","volume":"10","author":"J St. Sauver","year":"2017","unstructured":"St. Sauver J, Olson J, Roger V, Nicholson W, Black JL, Takahashi P, et al. CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications. PGPM. 2017;10:217\u201327.","journal-title":"PGPM"},{"key":"2271_CR15","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/pme.12464","volume":"15","author":"MG Kestenbaum","year":"2014","unstructured":"Kestenbaum MG, Vilches AO, Messersmith S, Connor SR, Fine PG, Murphy B, et al. Alternative Routes to Oral Opioid Administration in Palliative Care: A Review and Clinical Summary: Oral Opioid Alternatives in Palliative Care. Pain Med. 2014;15:1129\u201353.","journal-title":"Pain Med"},{"key":"2271_CR16","doi-asserted-by":"publisher","first-page":"32S","DOI":"10.1097\/PRS.0000000000000680","volume":"134","author":"RD Funk","year":"2014","unstructured":"Funk RD, Hilliard P, Ramachandran SK. Perioperative Opioid Usage: Avoiding Adverse Effects. Plastic Reconstructive Surg. 2014;134:32S\u201339S.","journal-title":"Plastic Reconstructive Surg"},{"key":"2271_CR17","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/BRS.0000000000003106","volume":"44","author":"DH Ge","year":"2019","unstructured":"Ge DH, Hockley A, Vasquez-Montes D, Moawad MA, Passias PG, Errico TJ, et al. Total Inpatient Morphine Milligram Equivalents Can Predict Long-term Opioid Use After Transforaminal Lumbar Interbody Fusion. Spine. 2019;44:1465\u201370.","journal-title":"Spine"},{"key":"2271_CR18","unstructured":"Sinatra RS. Acute Pain Management."},{"key":"2271_CR19","unstructured":"Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The Development and Validation of a Structured Diagnostic Psychiatric Interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 (Suppl 20):22\u201333."},{"key":"2271_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13355","volume":"29","author":"KE Dunn","year":"2024","unstructured":"Dunn KE, Huhn AS, Finan PH, Mange A, Bergeria CL, Maher BS, et al. Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype\u2013genotype assessment. Addiction Biol. 2024;29:e13355.","journal-title":"Addiction Biol"},{"key":"2271_CR21","unstructured":"R Core Team 2024. R: A Language and Environment for Statistical Computing_. R Foundation for Statistical Computing."},{"key":"2271_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"B Douglas","year":"2015","unstructured":"Douglas B, Martin M, Ben B, Steve W. Fitting Linear Mixed-Effects Models Using lme4. Journal Stat Softw. 2015;67:1\u201348. https:\/\/doi.org\/10.18637\/jss.v067.i01.","journal-title":"Journal Stat Softw"},{"key":"2271_CR23","doi-asserted-by":"publisher","unstructured":"Martinez S, Ellis JD, Bergeria CL, Huhn AS, Dunn KE. Treating Opioid Use Disorder and Opioid Withdrawal in the Context of Fentanyl. Ann Rev Clin Psychol. 2025. https:\/\/doi.org\/10.1146\/annurev-clinpsy-081423-023518.","DOI":"10.1146\/annurev-clinpsy-081423-023518"},{"key":"2271_CR24","doi-asserted-by":"publisher","first-page":"e0282536","DOI":"10.1371\/journal.pone.0282536","volume":"18","author":"A Zajacova","year":"2023","unstructured":"Zajacova A, Grol-Prokopczyk H, Limani M, Schwarz C, Gilron I. Prevalence and correlates of prescription opioid use among US adults, 2019\u20132020. PLoS ONE. 2023;18:e0282536.","journal-title":"PLoS ONE"},{"key":"2271_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","volume":"6","author":"J Strang","year":"2020","unstructured":"Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF, et al. Opioid use disorder. Nat Rev Dis Prim. 2020;6:3.","journal-title":"Nat Rev Dis Prim"},{"key":"2271_CR26","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","volume":"156","author":"KE Vowles","year":"2015","unstructured":"Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, Van Der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156:569\u201376.","journal-title":"Pain"},{"key":"2271_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1037\/1064-1297.16.5.429","volume":"16","author":"CM Bieber","year":"2008","unstructured":"Bieber CM, Fernandez K, Borsook D, Brennan MJ, Butler SF, Jamison RN, et al. Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: A pilot case-control study. Experimental Clin Psychopharmacol. 2008;16:429\u201334.","journal-title":"Experimental Clin Psychopharmacol"},{"key":"2271_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1360-0443.2006.01630.x","volume":"102","author":"A Agrawal","year":"2007","unstructured":"Agrawal A, Lynskey M, Madden P, Bucholz K, Heath A. A latent class analysis of illicit drug abuse\/dependence: Results from the National Epidemiological Survey on Alcohol and Related Conditions. Addiction. 2007;102:94\u2013104.","journal-title":"Addiction"},{"key":"2271_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/jnr.24643","volume":"100","author":"A Agrawal","year":"2022","unstructured":"Agrawal A, Jeffries PW, Srivastava AB, McCutcheon VV, Lynskey MT, Heath AC, et al. Retrospectively assessed subjective effects of initial opioid use differ between opioid misusers with opioid use disorder (OUD) and those who never progressed to OUD: Data from a pilot and a replication sample. J Neurosci Res. 2022;100:353\u201361.","journal-title":"J Neurosci Res"},{"key":"2271_CR30","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3390\/ph14111091","volume":"14","author":"AK Paul","year":"2021","unstructured":"Paul AK, Smith CM, Rahmatullah M, Nissapatorn V, Wilairatana P, Spetea M, et al. Opioid Analgesia and Opioid-Induced Adverse Effects: A Review. Pharmaceuticals. 2021;14:1091.","journal-title":"Pharmaceuticals"},{"key":"2271_CR31","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/j.1530-0277.2009.00984.x","volume":"33","author":"RS Trim","year":"2009","unstructured":"Trim RS, Schuckit MA, Smith TL. The Relationships of the Level of Response to Alcohol and Additional Characteristics to Alcohol Use Disorders Across Adulthood: A Discrete-Time Survival Analysis. Alcoholism Clin Exp Res. 2009;33:1562\u201370.","journal-title":"Alcoholism Clin Exp Res"},{"key":"2271_CR32","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1046\/j.1360-0443.2001.96690311.x","volume":"96","author":"MA Schuckit","year":"2001","unstructured":"Schuckit MA, Smith TL. The clinical course of alcohol dependence associated with a low level of response to alcohol. Addiction. 2001;96:903\u201310.","journal-title":"Addiction"},{"key":"2271_CR33","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1530-0277.2008.00645.x","volume":"32","author":"RS Trim","year":"2008","unstructured":"Trim RS, Schuckit MA, Smith TL. Level of Response to Alcohol Within the Context of Alcohol-Related Domains: An Examination of Longitudinal Approaches Assessing Changes Over Time. Alcoholism Clin Exp Res. 2008;32:472\u201380.","journal-title":"Alcoholism Clin Exp Res"},{"key":"2271_CR34","unstructured":"Newlin DB, Thomson JB. Chronic Tolerance and Sensitization to Alcohol in Sons of Alcoholics: II. Replication and Reanalysis."},{"key":"2271_CR35","doi-asserted-by":"publisher","first-page":"368","DOI":"10.15288\/jsa.1996.57.368","volume":"57","author":"MA Schuckit","year":"1996","unstructured":"Schuckit MA, Tsuang JW, Anthenelli RM, Tipp JE, Nurnberger JI. Alcohol challenges in young men from alcoholic pedigrees and control families: a report from the COGA project. J Stud Alcohol. 1996;57:368\u201377.","journal-title":"J Stud Alcohol"},{"key":"2271_CR36","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neubiorev.2021.07.036","volume":"130","author":"R Brewer","year":"2021","unstructured":"Brewer R, Murphy J, Bird G. Atypical interoception as a common risk factor for psychopathology: A review. Neuroscience Biobehav Rev. 2021;130:470\u2013508.","journal-title":"Neuroscience Biobehav Rev"},{"key":"2271_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/17425255.2022.2085552","volume":"18","author":"P Ballester","year":"2022","unstructured":"Ballester P, Muriel J, Peir\u00f3 AM. CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesia. Expert Opin Drug Metab Toxicol. 2022;18:261\u201375.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2271_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13418","volume":"29","author":"S Leknes","year":"2024","unstructured":"Leknes S, Eikemo M, L\u00f8seth G. Understanding individual variability in opioid responses: A call to arms. Addiction Biol. 2024;29:e13418.","journal-title":"Addiction Biol"},{"key":"2271_CR39","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3389\/fpsyt.2019.00750","volume":"10","author":"VK Schaan","year":"2019","unstructured":"Schaan VK, Schulz A, Rubel JA, Bernstein M, Domes G, Sch\u00e4chinger H, et al. Childhood Trauma Affects Stress-Related Interoceptive Accuracy. Front Psychiatry. 2019;10:750.","journal-title":"Front Psychiatry"},{"key":"2271_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/psyp.13429","volume":"56","author":"D Schultchen","year":"2019","unstructured":"Schultchen D, Bayer J, K\u00fchnel J, Melchers KG, Pollatos O. Interoceptive accuracy is related to long-term stress via self-regulation. Psychophysiology. 2019;56:e13429.","journal-title":"Psychophysiology"},{"key":"2271_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13047","volume":"26","author":"M Carlyle","year":"2021","unstructured":"Carlyle M, Broomby R, Simpson G, Hannon R, Fawaz L, Mollaahmetoglu OM, et al. A randomised, double-blind study investigating the relationship between early childhood trauma and the rewarding effects of morphine. Addiction Biol. 2021;26:e13047.","journal-title":"Addiction Biol"},{"key":"2271_CR42","doi-asserted-by":"publisher","first-page":"11056","DOI":"10.1073\/pnas.0702413104","volume":"104","author":"TD Wager","year":"2007","unstructured":"Wager TD, Scott DJ, Zubieta J-K. Placebo effects on human \u03bc-opioid activity during pain. Proc Natl Acad Sci USA. 2007;104:11056\u201361.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2271_CR43","doi-asserted-by":"publisher","first-page":"7754","DOI":"10.1523\/JNEUROSCI.0439-05.2005","volume":"25","author":"J-K Zubieta","year":"2005","unstructured":"Zubieta J-K, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, et al. Placebo Effects Mediated by Endogenous Opioid Activity on \u03bc-Opioid Receptors. J Neurosci. 2005;25:7754\u201362.","journal-title":"J Neurosci"},{"key":"2271_CR44","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1097\/j.pain.0000000000002478","volume":"163","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chan E, Dorsey SG, Campbell CM, Colloca L. Who are the placebo responders? A cross-sectional cohort study for psychological determinants. Pain. 2022;163:1078\u201390.","journal-title":"Pain"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02271-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02271-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02271-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T23:02:24Z","timestamp":1765926144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02271-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2271"],"URL":"https:\/\/doi.org\/10.1038\/s41386-025-02271-4","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}